CSIMarket
 


Organogenesis Holdings Inc   (ORGO)
Other Ticker:  
 

Cumulative Organogenesis Holdings Inc 's Working Capital Ratio for Trailing Twelve Months Period

ORGO's Working Capital Ratio for Trailing Twelve Months Period and Current Assets, Current Liabilities growth


Select the Comparisons : Select the Ratio:

ORGO Working Capital Ratio for Trailing Twelve Months Period

(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Current Liabilities Growth 10.21 % 4.36 % 3.76 % 20.21 % 22.27 %
Y / Y Current Assets Growth 8.82 % 14.76 % 17.61 % 30.19 % 64.2 %
Working Capital Ratio for Trailing Twelve Months Period 2.7 2.71 2.65 2.57 2.51
Total Ranking # 1470 # 1946 # 2044 # 2216 # 1750
Seq. Current Liabilities Growth 1.18 % 14.89 % -6.36 % 1.24 % -4.19 %
Seq. Current Assets Growth -0.44 % 6.29 % -4.02 % 7.15 % 4.99 %


Working Capital Ratio for Trailing Twelve Months Period Comment
On the trailing twelve months basis Due to rise in Current Liabilities in the III. Quarter to $89 millions, average cumulative Working Capital Ratio for Trailing Twelve Months Period decreased to 2.7 below Organogenesis Holdings Inc average Working Capital Ratio for Trailing Twelve Months Period.
Working Capital Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies operatig within Major Pharmaceutical Preparations industry 367 other companies have achieved higher Working Capital Ratio for Trailing Twelve Months Period than Organogenesis Holdings Inc . While Working Capital Ratio for Trailing Twelve Months Period overall ranking has improved so far to 1470, from total ranking in previous quarter at 1946.

What is Working Capital Ratio?
More about ORGO
Working Capital Ratio ORGO in the most recent quarter
Working Capital Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 368
Sector # 700
S&P 500 # 1469


Working Capital Ratio for Trailing Twelve Months Period Statistics
High Average Low
2.71 2.12 1.29
(Jun 30 2022)   (Jun 30 2019)




Companies with similar average Working Capital Ratio for Trailing Twelve Months Period for 12 months ending Sep 30 2022, within Major Pharmaceutical Preparations Industry Working Capital Ratio for Trailing Twelve Months Period
Zynerba Pharmaceuticals Inc   7.41 
Veru Inc.  7.40 
Transcode Therapeutics Inc   7.39 
Nektar Therapeutics  7.36 
Siga Technologies Inc  7.35 
Gossamer Bio Inc   7.24 
Praxis Precision Medicines Inc   7.19 
Xencor Inc  7.17 
Blue Water Vaccines Inc   7.15 
Ngm Biopharmaceuticals Inc   7.12 
Schrodinger Inc   7.11 
Mainz Biomed N v   7.11 
Marinus Pharmaceuticals Inc   7.10 
Landos Biopharma Inc   7.09 
Celsion Corporation  7.09 
Sesen Bio Inc   7.08 
Royalty Pharma Plc  7.05 
Angion Biomedica Corp  7.04 
Geovax Labs Inc   7.04 
Clene Inc   7.02 
Oncorus Inc   7.00 
89bio Inc   6.89 
Mei Pharma Inc   6.85 
Iterum Therapeutics Plc  6.80 
Ideaya Biosciences Inc   6.79 
Ocular Therapeutix Inc   6.76 
Clearside Biomedical Inc   6.73 
Durect Corp  6.63 
Apellis Pharmaceuticals Inc   6.60 
Catalyst Biosciences Inc   6.59 


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

DNAWS's Profile

Stock Price

DNAWS's Financials

Business Description

Fundamentals

Charts & Quotes

DNAWS's News

Suppliers

DNAWS's Competitors

Customers & Markets

Economic Indicators

DNAWS's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071